Cancer Immunology Research | American Association for Cancer Research

Skip Nav Destination

Current Issue

Volume 12,

Issue 9

1 September 2024

About the Journal

Cancer Immunology Research publishes outstanding original articles reporting major advances in cancer immunology that span the discipline from basic investigations in host-tumor interactions to developmental therapeutics in model systems, early translational studies in patients, and late-stage clinical trials. Read More About the Journal

Editors-in-Chief

Robert D. Schreiber
Philip D. Greenberg

View Full Editorial Board

Impact Factor

8.1

SUBMIT TO JOURNAL

Featured Articles

Pancreatic Epithelial IL17/IL17RA Signaling Drives B7-H4 Expression to Promote Tumorigenesis

Susana Castro-Pando, et al.

Nivolumab Reaches Brain Lesions in Patients with Recurrent Glioblastoma and Induces T-cell Activity and Upregulation of Checkpoint Pathways

Signe K. Skadborg, et al.

Intracellular Osteopontin Promotes the Release of TNFα by Mast Cells to Restrain Neuroendocrine Prostate Cancer

Roberta Sulsenti, et al.

Trending - Altmetric

The article titled, The Dark Knight: Functional Reprogramming of Neutrophils in the Pathogenesis of Colitis-Associated Cancer, has an Alt Metric Attention Score of 11.75. Click to see more of this article's metrics.

Read the article titled, The Dark Knight: Functional Reprogramming of Neutrophils in the Pathogenesis of Colitis-Associated Cancer

Last mentioned on Monday September 16 2024

The article titled, Inflammation mediated by gut microbiome alterations promotes lung cancer development and an immunosuppressed tumor microenvironment, has an Alt Metric Attention Score of 5.33. Click to see more of this article's metrics.

Read the article titled, Inflammation mediated by gut microbiome alterations promotes lung cancer development and an immunosuppressed tumor microenvironment

Last mentioned on Sunday September 15 2024

The article titled, Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors, has an Alt Metric Attention Score of 18.25. Click to see more of this article's metrics.

Read the article titled, Generation of Potent T-cell Immunotherapy for Cancer Using DAP12-Based, Multichain, Chimeric Immunoreceptors

Last mentioned on Tuesday September 10 2024

The article titled, The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity, has an Alt Metric Attention Score of 48.58. Click to see more of this article's metrics.

Read the article titled, The Nonsignaling Extracellular Spacer Domain of Chimeric Antigen Receptors Is Decisive for In Vivo Antitumor Activity

Last mentioned on Tuesday September 10 2024

The article titled, PTPRZ1-targeting RNA CAR T cells exert antigen-specific and bystander antitumor activity in glioblastoma, has an Alt Metric Attention Score of 2.5. Click to see more of this article's metrics.

Read the article titled, PTPRZ1-targeting RNA CAR T cells exert antigen-specific and bystander antitumor activity in glioblastoma

Last mentioned on Monday September 16 2024

Latest
Most Read
Most Cited

Peripheral blood–derived PD-1/CD28–CD19-CAR–modified PD-1+ T-cell therapy in patients with solid tumors

CD91 and its ligand gp96 confer cross-priming capabilities to multiple APCs during immune responses to nascent, emerging tumors

Inflammation mediated by gut microbiome alterations promotes lung cancer development and an immunosuppressed tumor microenvironment

The Dark Knight: Functional Reprogramming of Neutrophils in the Pathogenesis of Colitis-Associated Cancer